Last updated on November 2017

Efficacy, Immunogenicity, and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection


Brief description of study

Efficacy, Immunogenicity, and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection

Detailed Study Description

The aim of this study is to evaluate the efficacy of the candidate Clostridium difficile (C. difficile) vaccine to prevent primary symptomatic C. difficile infection (CDI) in subjects a risk for CDI where there is a substantial unmet medical need.

Clinical Study Identifier: TX81789

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Pensacola Research Consultants Inc.

Pensacola Research Consultants Inc.
Pensacola, FL USA
  Connect »